AusPAR: Daclizumab

Australian Public Assessment Report

AusPAR

AusPAR: Daclizumab [PDF, 1.31 MB]

AusPAR: Daclizumab [DOCX, 2.44 MB]

Attachment: Product Information: Daclizumab [PDF, 300.66 KB]

Attachment: Product Information: Daclizumab [DOCX, 176.45 KB]

Attachment: Extract from Clinical Evaluation Report: Daclizumab [PDF, 2.52 MB]

Attachment: Extract from Clinical Evaluation Report: Daclizumab [DOCX, 7.28 MB]

Attachment: Extract from Supplementary Clinical Evaluation Report: Daclizumab [PDF, 4.3 MB]

Attachment: Extract from Supplementary Clinical Evaluation Report: Daclizumab [DOCX, 11.46 MB]

Device/Product Name

Zinbryta

Active ingredients

Daclizumab

AusPAR Date

4 May 2017

Published

12 May 2017

Submission Number

PM-2015-01556-1

Submission Type

New chemical entity

Decision

Approved

Product types

Prescription medicines